Influence of physical factors in gastrointestinal tract on acetaminophen release from controlled-release tablets in fasted dogs

被引:40
作者
Sako, K
Mizumoto, T
Kajiyama, A
Ohmura, T
机构
[1] Novel Pharma Research Laboratories, Yamanouchi Pharmaceutical Co., Ltd., Shizuoka 425, 180 Ozumi, Yaizu-shi
关键词
acetaminophen; controlled-release; colonic release; gastrointestinal transit; mechanical destructive forces; agitation intensity;
D O I
10.1016/0378-5173(96)04524-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Four types of controlled-release (CR) acetaminophen (AAP) tablets, namely A, B, C and D, were prepared to investigate the influence of physical factors in the gastrointestinal (GI) tract on AAP release in fasted dogs. CR-A was designed as a completely resistant formulation to mechanical destructive force but to show an agitation speed-dependent dissolution rate. CR-B, CR-C and CR-D were designed to have different wet strengths but to show similar dissolution rates. The absorption profiles of the four CR forms in dogs showed biphasic patterns, with phase change about 2 h after oral dosing. The first phase of the absorption profile of CR-A and in vivo release directly observed were close to its in vitro profiles at a speed of 25-50 revs./min, indicating that agitation intensity in the dog GI tract may be relatively low. The first phase of the absorption profiles of the CR-B, CR-C and CR-D differed from each other, despite the fact that dissolution rates in vitro were similar. The tablet with low wet strength showed a faster absorption rate, indicating that it would be destructed by GI mechanical forces. Furthermore, absorption during the second phase was extremely low for all CR tablets. We confirmed on necroscopy that the suppression of drug absorption in the second phase was caused by the termination of AAP release from the tablets in the colon. These results will be useful in evaluating the in vivo performance of CR tablets in fasted dogs.
引用
收藏
页码:225 / 232
页数:8
相关论文
共 13 条
[1]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF ACETAMINOPHEN IN PLASMA - SINGLE-DOSE PHARMACOKINETIC STUDIES [J].
AMEER, B ;
GREENBLATT, DJ ;
DIVOLL, M ;
ABERNETHY, DR ;
SHARGEL, L .
JOURNAL OF CHROMATOGRAPHY, 1981, 226 (01) :224-230
[2]   DETERMINATION OF THE MECHANICAL IMPACT FORCE IN THE IN-VITRO DISSOLUTION TEST AND EVALUATION OF THE CORRELATION BETWEEN IN-VIVO AND IN-VITRO RELEASE [J].
AOKI, S ;
ANDO, H ;
TATSUISHI, K ;
UESUGI, K ;
OZAWA, H .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 95 (1-3) :67-75
[3]   DOG AS A QUANTITATIVE MODEL FOR EVALUATION OF NONDISINTEGRATING SUSTAINED-RELEASE TABLETS [J].
CRESSMAN, WA ;
SUMNER, D .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (01) :132-&
[4]   MATHEMATICAL-MODELING OF DRUG RELEASE FROM HYDROXYPROPYLMETHYLCELLULOSE MATRICES - EFFECT OF TEMPERATURE [J].
FORD, JL ;
MITCHELL, K ;
ROWE, P ;
ARMSTRONG, DJ ;
ELLIOTT, PNC ;
ROSTRON, C ;
HOGAN, JE .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 71 (1-2) :95-104
[5]   ESTIMATION OF DRUG ABSORPTION RATES USING A DECONVOLUTION METHOD WITH NONEQUAL SAMPLING TIMES [J].
IGA, K ;
OGAWA, Y ;
YASHIKI, T ;
SHIMAMOTO, T .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1986, 14 (02) :213-225
[6]   ESTIMATION OF AGITATION INTENSITY IN THE GI TRACT IN HUMANS AND DOGS BASED ON IN-VITRO IN-VIVO CORRELATION [J].
KATORI, N ;
AOYAGI, N ;
TERAO, T .
PHARMACEUTICAL RESEARCH, 1995, 12 (02) :237-243
[7]   INVITRO AND INVIVO CORRELATION FOR CONTROLLED-RELEASE FORMULATION OF D-CHLORPHENIRAMINE MALEATE [J].
KATORI, N ;
OKUDAIRA, K ;
AOYAGI, N ;
TAKEDA, Y ;
UCHIYAMA, M .
JOURNAL OF PHARMACOBIO-DYNAMICS, 1991, 14 (10) :567-575
[8]  
KIMURA T, 1994, BIOL PHARM BULL, V17, P327
[9]   COMPARISON OF GASTROINTESTINAL PH IN DOGS AND HUMANS - IMPLICATIONS ON THE USE OF THE BEAGLE DOG AS A MODEL FOR ORAL ABSORPTION IN HUMANS [J].
LUI, CY ;
AMIDON, GL ;
BERARDI, RR ;
FLEISHER, D ;
YOUNGBERG, C ;
DRESSMAN, JB .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (03) :271-274
[10]  
OGATA H, 1984, INT J CLIN PHARM TH, V22, P240